Trench Fever Treatment Market size was over USD 142.3 million in 2023 and is poised to cross USD 322.66 million by 2036, growing at more than 6.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of trench fever treatment is evaluated at USD 149.7 million. The growth of the market can be attributed largely to the rising outbreaks of trench fever across the globe, and increasing number of patients of infections caused by bacteria. According to the data provided by the Centers for Disease Control and Prevention (CDC) in 2019, antibiotic resistant fungi and bacteria cause more than 2.8 million infections and about 35,000 deaths in the United States every year. In addition, trench fever is most common in populations living in shelters who either have no access to clean clothes or abuse alcohol. Thus, presence of environments with unsanitary conditions is also a crucial factor expected to accelerate the growth of the market in the near future. Furthermore, growing venture funding and allocation of large budgets by government in the healthcare sector is projected to offer lucrative opportunities to the market in the upcoming years.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
4.6% |
|
Base Year Market Size (2023) |
USD 820.3 billion |
|
Forecast Year Market Size (2036) |
USD 1407.2 billion |
|
Regional Scope |
|
The market is segmented by treatment into doxycycline, tetracycline, chloramphenicol, and others, out of which, the doxycycline segment is anticipated to hold the largest share in the global trench fever treatment market. This can be accounted to the efficiency of doxycycline in treating infections by preventing the spread and growth of bacteria. Apart from this, the ability of this drug to treat fever and minor complications within 24-48 hours since the inception of treatment is also predicted to boost the growth of the market segment in the imminent time. Additionally, on the basis of end user, the hospitals segment is evaluated to grab the largest share over the forecast period, which can be credited to the high emphasis of patients all around the world to be treated under the supervision of a healthcare professional in a hospital facility.
Our in-depth analysis of the global trench fever treatment market includes the following segments:
|
By Treatment |
|
|
By End User |
|
|
By Drug Distribution Channel
|
|
On the basis of geographical analysis, the global trench fever treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. North America industry is expected to account for largest revenue share by 2036, on the back of sudden emergence of cases of people with trench fever, and upsurge in healthcare spending in the region. As per the Centers for Medicare and Medicaid Services, the healthcare spending in the United States reached a value of USD 3.8 trillion, or USD 11,582 per person in 2019. The health spending accounted for 17.7 percent of the nation’s GDP. In addition, increase in population abusing alcohol and narcotic substances is also assessed to propel the region’s market growth in the coming years. Moreover, the market in Europe is also anticipated to grab a notable share owing to fact that the fever originated there, and high prevalence of the fever in poverty-stricken areas of the region.
A study in December, 2020 suggested that trench fever, which was common amongst soldiers during the First World War, has been reported among some Canadians who are experiencing homelessness.
Another outbreak of the fever was found in Denver, United States in July, 2020. A total of 4 persons were discovered suffering from this fever caused by bacterium Bartonella quintana.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?